Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 14 September, 2021 Riyadh

The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.